ADCT vs VRTX: Which Stock is Better?

Side-by-side comparison of ADC Therapeutics SA and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

ADCT

ADC Therapeutics SA

$3.52

VRTX

Vertex Pharmaceuticals Inc

$442.08

Key Metrics Comparison

MetricADCTVRTXWinner
Market Cap$436.05M$113.16BVRTX
P/E RatioN/A31.06VRTX
EPS (TTM)$N/A$14.21VRTX
Revenue Growth-0.1%0.1%VRTX
Gross Margin-57.4%52.7%VRTX

Analyze ADCT

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ADCT or VRTX a better investment?

Comparing ADCT and VRTX: ADC Therapeutics SA has a market cap of $436.05M while Vertex Pharmaceuticals Inc has $113.16B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ADCT and VRTX?

ADCT (ADC Therapeutics SA) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ADCT or VRTX?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ADCT or VRTX?

VRTX has higher revenue growth at 0.1% vs -0.1% for ADCT.

Which company is more profitable: ADCT or VRTX?

Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 52.7% compared to -57.4% for ADCT.

Which is the larger company: ADCT or VRTX?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $113.16B compared to $436.05M for ADCT.

Should I buy ADCT or VRTX in 2026?

Both ADCT and VRTX have investment merit. ADCT trades at $3.52 while VRTX trades at $442.08. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ADCT and VRTX stock?

Key differences: Market Cap ($436.05M vs $113.16B), P/E Ratio (N/A vs 31.1x), Revenue Growth (-0.1% vs 0.1%), Gross Margin (-57.4% vs 52.7%).

Popular Stock Comparisons